Filing Details
- Accession Number:
- 0000899243-17-005252
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-24 18:00:41
- Reporting Period:
- 2017-02-15
- Filing Date:
- 2017-02-24
- Accepted Time:
- 2017-02-24 18:00:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1066040 | Jr E Francis Odonnell | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-15 | 7,965 | $0.00 | 147,636 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-02-15 | 70,000 | $0.00 | 217,636 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-02-15 | 48,419 | $0.00 | 266,055 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-02-15 | 133,334 | $0.00 | 399,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-15 | 39,544 | $1.95 | 359,845 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-16 | 83,900 | $1.89 | 275,945 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-17 | 6,416 | $1.85 | 269,529 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2017-02-15 | 7,965 | $0.00 | 7,965 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2017-02-15 | 70,000 | $0.00 | 70,000 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2017-02-15 | 48,419 | $0.00 | 48,419 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2017-02-15 | 133,334 | $0.00 | 133,334 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-15 | 2017-02-15 | No | 4 | A | Direct |
| 0 | 2017-02-15 | 2017-02-15 | No | 4 | M | Direct |
| 48,418 | 2017-02-15 | 2017-09-13 | No | 4 | M | Direct |
| 266,666 | 2017-02-15 | 2018-02-23 | No | 4 | M | Direct |
Footnotes
- The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's Long Term Incentive Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 70,000 RSUs granted to the Reporting Person on February 20, 2013 under the Issuer's 2011 Equity Incentive Plan, as amended (the "Plan"). Pursuant to a deferral, these RSUs vested on February 15, 2017.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on February 22, 2014 under the Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017. Pursuant to a deferral, the remaining half of the RSUs under this grant will vest on September 13, 2017.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015 under the Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on each of (i) September 14, 2017 and (ii) February 23, 2018.
- The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
- On February 15, 2017, the Reporting Person sold an aggregate of 39,544 shares of the Issuer's Common Stock at a weighted average price of $1.95 per share. The highest sale price for the Common Stock was $2.00 per share and the lowest sale price was $1.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- On February 16, 2017, the Reporting Person sold an aggregate of 83,900 shares of the Issuer's Common Stock at a weighted average price of $1.89 per share. The highest sale price for the Common Stock was $1.95 per share and the lowest sale price was $1.85 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
